These results manifested the molecular link of obesity through the treatment of AWL inhibited the expression of aP2, which facilitate AWL driven suppression of adipogenesis via the downregulation of C/EBPα and PPARγ on molecular dysregulation in disease complications such as obesity. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.